Alaunos Therapeutics | ZIOP - Ebitda





Ebitda Veränderung Datum
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Baxter International USD 309M 756M 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bioline Rx USD -2.25M 1.7M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Celltrion KRW 19.64B 1.85B 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Curis USD -12.3M 231K 2023-09
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Divis Laboratories Ltd INR 12.62B 3.28B 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.27B 1.08B 2026-03
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD -1.54B 7.84B 2026-03
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Novartis USD 6.48B 1.19B 2026-06
Organigram Holdings CAD -4.76M 10.02M 2026-03
Pfizer USD 6.01B 18M 2026-06
Pharma Mar EUR 700K 2.01M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Qiagen NV USD 207.66M 59.56M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sartorius EUR 280.5M 13.2M 2026-06
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
TG Therapeutics USD 26.9M 1.21M 2026-06
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -379M 348.47M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03